Introduction
The minimum infectious dose (MID) varies for different viruses, and is probably influenced by host factors such as virus-inactivating molecules present at different body sites as well as the route of exposure (Ward & Akin, 1984) . When the virus is sequestered in the form of virus-infected cells, viruses may be able to avoid internal lines of defence, leading to the potential for virus-infected cells to spread infection (Levy, 1988; Sabin, 1991 Sabin, , 1992 . Few if any studies are available which directly address the problem of whether virus-infected ceils are efficient vehicles for infection delivery. Therefore, we have examined the role of lactate dehydrogenase-elevating virus (LDV)-infected macrophages in mediating LDV-infection of mice and also assessed the body distribution of exogenous macrophages which could serve as virus delivery vehicles. Witliam A. Cafruny. Fax + 1 605 677 5658. e-mail bcafruny@sundance.usd.edu LDV is a macrophage-tropic arterivirus of mice (Plagemann & Moennig, 1992; Plagemann et al., 1995) and is composed of a spherical [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] nm nucleocapsid core containing a linear 13-15 kb ssRNA genome as well as a 12-14 kDa nucleocapsid protein. The virus envelope contains a non-glycosylated 18-19 kDa protein (VP-2), one primary glycoprotein (VP-3P) and one minor glycoprotein (VP-3M). LDV undergoes rapid replication in vivo, with new virions detectable in blood within 4-5 h post-infection (p.i.) (Plagemann & Moennig, 1992; Plagemann et al., 1995; Cafruny et al., 1996) . LDV invariably establishes a persistent infection of mice, characterized by viraemia in the form of infectious LDV-IgG complexes (Cafruny & Plagemann, 1982a) . LDV has a high efficiency of infection via parenteral routes, with essentially one virion representing the parenteral MID Cafruny & Hovinen, 1988) . In contrast, there is a strong mucosal barrier to LDV infection and infection at mucosal sites is highly inefficient, requiring 103'3-105.3 virions depending on the anatomical location (Cafruny & Hovinen, 1988) . Persistent LDV infection of testis tissue has recently been described, suggesting the possibility of LDV release in semen and sexual transmission (Anderson eta/., 1995) . Thus, LDV provides an ideal model for transmission studies.
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We report here the results of experiments designed to track the distribution of macrophages in mice after in vitro labelling with the fluorescent dye I,l'-dioctadecyl 3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI), a stable hydrophobic macrophage membrane marker (Rosen & Gordon, 1990) . The use of this fluorescent dye permitted detection of labelled exogenous macrophages in various mouse tissues over a period of several days post-delivery. Macrophages were found to be broadly distributed after intravenous (i.v.) or intraperitoneal (i.p.) delivery to normal mice, but macrophage access was restricted to the placenta after intravaginal delivery to pregnant mice. Intravaginal delivery of LDV-infected macrophages resulted in systemic LDV infection, despite the strong vaginal barrier to free virus. Dual-labelling experiments, in which LDV antigen was determined by an indirect immunoflorescence assay (IFA), also demonstrated the penetration of DiI-labelled and LDV-infected macrophages into placenta following i.v. injection. These results provide evidence for the capacity of macrophages to mediate sexually transmitted virus infection.
Methods
• Mice, Outbred CFI mice were purchased from Sasco. BALB/c mice were obtained from the Jackson Laboratory. C57BL/6 mice were a generous gift from the transgenic colony of Dr R. Miskimins (University of South Dakota, USA). All mice were maintained on standard laboratory food and tap water ad lib.
• Macrophages and Dil labelling. Mouse peritoneal cells were harvested by lavage with serum-flee MEM, washed once in serum-free medium, and incubated with 4 gg/ml DiI (Molecular Probes) at 37 °C for 10 rain as described (Rosen & Gordon, 1990) ; the reaction was quenched with serum-containing medium. The efficiency of labelling ranged from approximately 30--00%, as determined by observation of labelled cells under a fluorescence microscope (red fluorescence, ~ 580 nm).
• Virus and virus infections. The LDV P strain (Cafruny & Plagemann, 1982b) was maintained as frozen (--70 °C) plasma stocks containing about 100 ID~0/ml. Mice were infected by i.p. or Lv. injection of 0"1 ml PBS containing 10 ~ IDs0 LDV, as described in Results. Virus infection was assayed in mice by lactate dehydrogenase determination at 4-5 days post-injection (Plagemann & Moennig, 1992) . Virus-infected macrophages for intravaginal injection were prepared by harvesting peritoneal macrophages at 6-16 h after i.v. LDV inoculation. The cells were maintained on ice and washed three times with PBS pH 7"4, pelleting the cells between washes at 756 g for 5 rain. Supematant virus titres were obtained for the final cell preparations prior to injection into mice. For i.v. double labelling experiments, peritoneal macrophages were labelled with DiI as described above, and then LDV-infected in vitro for 15-30 min prior to infection by the i.v. route.
• IFA for LDV-infected macrophages. In situ IFA was carried out on frozen tissue samples which were sectioned to b I~m in a cryostat, placed on glass coverslips, and fixed with acetone for 5 rain (modified from Cafruny et at., 1986) . In the double labelling experiments, the time of acetone fixation was reduced to 15 s. The source of primary anti-LDV antibody was pooled plasma from chronically LDV-infected CF1 mice, containing high titre ( > 1:3200) IgG anti-LDV antibodies (Cafruny et al., 1986) . Following incubation with a 1:50 dilution of this primary antibody, the sections were washed and incubated with FITC-conjugated goat anti-mouse IgG (affinity-adsorbed, Fc-specific; Sigma). The sections were then examined under a fluorescence microscope (green fluorescence, 520 nm). IFA for detection of LDV-infected cultured macrophages was carried out as described (Cafruny et aI., I986) , using the same primary and secondary antibodies. Negative controls consisted of tissue or cell preparations from mock-infected animals.
• Macrophage tracking assay. DiI-labeIled peritoneal macrophages were injected by tail vein, i.p. or vaginally (Cafruny & Hovinen, 1988) as described in the Results. Between 4-72 h later, the mice were sacrificed and placentas, fetuses or other tissues as described in Results were obtained and frozen in OCT embedding medium (Miles) at -70 °C. In some experiments, the mice were perfused by cutting the right atrium and injecting 10 ml PBS via the left ventricle prior to obtaining tissues. The frozen tissue blocks were then sectioned to 6 p.m in a cryostat, placed on glass coverslips and examined under a fluorescence microscope. For most tissue blocks, 16 sections with 50--100 gm between each section were analysed.
Results

Tissue distribution of Dil-labelled macrophages following in vivo injection
Peritoneal cells were harvested from CF1 mice, labelled with DiI and injected i.p. or i.v. into normal CF1 mice. Tissue samples were obtained from the mice at various times postinjection, frozen in OCT embedding medium and sectioned in a cryostat. As described earlier, lb sections per tissue block were examined under a fluorescence microscope in order to determine the presence of DiI-labelled cells. Data combined in Table I show that DiI-labelled cells rapidly became distributed throughout the body following i.v. injection, with the greatest concentration found in liver, spleen and lung. Other tissues, for example brain, spinal cord and testis, had low but detectable levels of DiI-labelled cells. Perfusion of the animals did not have a significant effect on these findings ( Table 1 ), suggesting that most macrophages were adherent to or had penetrated vascular endothelia. When 4"7 x 106 DiI-labelled macrophages were injected i.v., the blood concentration of DiI-labelled cells rapidly declined over a 4 h period post-injection (b x 105, 5 x 105 and I x 105 DiI-labelled cells per ml at 5 min, 45 min and 4 h post-injection, respectively) but significant numbers of cells (about I0a/ml) remained at b days post-injection. Mice receiving DiI-labelled cells by the i.p. route displayed similar tissue distributions but reduced numbers of cells per section (data not shown), indicating less efficient macrophage delivery. DiI-labelled normal macrophages were also found to home to the placentas of pregnant mice after i.v. or i.p. injection, and LDV infection of the macrophages prior to Di] labelling had no effect on placental homing ( Table 2 ). The results of extensive fetal sampling were negative in these studies (data not shown), demonstrating the fetal-placental cell barrier. Combined, these 00( Table 3 for additional quantitative data.
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Fate of intravaginally administered Dil-labelled macrophages
In order to determine the fate of intravaginally injected macrophages, pregnant mice at 14-18 days of gestation were given vaginal injections of DiI-labelled macrophages. At 18-72 h after injection, the mice were sacrificed and frozen sections of placental, fetal or other tissues were examined under a fluorescence microscope. Data combined in Table 2 show that DiI-labelled cells were observed in some but not all placentas. DiI-labelled cells were also found locally in vaginal tissue (data not shown). There was no apparent effect of timing over the range studied, but placentas from two of the mice were completely negative for DiI-labelled cells, indicating that unknown variables contribute to the regulation of placental penetration by intravaginal macrophages. Vaginally administered DiI-labelled cells were never observed in fetuses ( > 100 sections from > 7 fetuses screened), spleens, blood or any other tissues examined (data not shown). The migration of DiIlabelled cells from vagina to placenta was dependent upon the position of the placenta, since only placentas located proximal to the cervix contained labelled macrophages (Table 3) . Placentas located near the tip of the uterine horns lacked any detectable DiI-labelled cells and positive placentas further from the cervix displayed progressively reduced numbers of DiIpositive cells (Table 3) . However, in contrast to i.v.-injected macrophages, which homed to the blood sinuses of the placenta, vaginally-injected macrophages were found to reside closer to the surface and outside of the placental labyrinth. These results demonstrate the selective migration of intravaginal macrophages to the placenta during the period of 18-72 h post-vaginal injection, which was not a result of systemic access.
Systemic LDV infection following vaginal administration of LDV-infected macrophages
LDV-infected macrophages were obtained from donor LDV-infected CF1 mice and injected vaginally into indicator CF1 mice, which were assayed for LDV infection 5 days later. Preliminary studies were carried out to correlate the timing of infected peritoneal macrophage harvest with the detection of LDV-infected cells by IFA as well as the titre of free virus in cell pellet supematants. Mice were LDV-infected by i.v. injection, peritoneal cells were obtained at 4, 8, 10, 12, 14, 16 and 20 h p.i. and washed twice prior to screening for LDV infection and virus levels in the final suspensions. The percentage of LDVpositive cells as determined by IFA was found to be 1"5, 1"5, 3"0, 4"0, 7"0, 15 and 2"5 %, respectively. Supernatant LDV titres (IDs0/ml) were 103"°, 105°, 105°, 1075, 107.5 and 105.0 at the same time points. These results reflect the rapid acute phase of LDV infection in vivo, in which viraemia of up to 108 IDs0/ml may appear within 4--6 h p.i. and also show that virus infection is emerging and detectable at low levels in peritoneal macrophages harvested at 4-8 h p.i. In other experiments (data not shown) a third cell wash reduced the supematant virus titres about 10-fold. Therefore, peritoneal cells obtained between 4-20 h p.i. and washed three times were considered to be appropriate vehicles for virus delivery studies, since supematant titres of free virus would contribute a dose below the threshold level for vaginal infection of 105.3 IDs0 (Cafruny & Hovinen, 1988 ; see below) when the cell inoculum was 10,1 or less. Furthermore, in the infected cell experiments described below, the data sets were separated according to different times p.i. to segregate the analyses by supematant free virus titres. Table 4 summarizes the results of experiments in which mice were vaginally exposed to free LDV or LDV-infected peritoneal macrophages as infectious vehicles in a total volume of 7-10,1. In a previous study (Cafruny & Hovinen, 1988) , the MID by the vaginal route was found to range from 105.3 to > 106.3 IDs0. The data in Table 4 confirm this threshold for free virus vaginal MID, since some mice remained uninfected after vaginal doses of 105"5-105.6 IDs0. When mice were vaginally exposed to LDV-infected macrophages obtained at 7-8, 13-16 or 12 h p.i. (Table 4 , cell-associated infection experiments 1, 2 and 3, respectively), the rate of infection ranged from 9"9--60 % and was proportional to the timing of donor cell infection. In these experiments, the free virus dose was below the MID Table 4 ), indicating that the virus-carrying cells were necessary for induction of infection; this was confirmed by the failure of the supernatant control (Table 4) to induce infection. Thus, macrophages carrying LDV are efficient vehicles for systemic LDV infection when injected intravaginally.
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Failure of locally administered anti-virus antibodies to protect against infection from vaginally-injected LDVinfected cells
In a separate series of experiments, mice were pretreated with anti-virus IgG antibodies prior to vaginal injection of LDV-infected cells. Pretreatment regimens were intravaginal injection of either pooled plasma of chronically LDV-infected mice containing IgG anti-LDV titre of 1:8000 (Cafruny & Plagemann, I982a) or of an ascites preparation of the 159-I2 MAb to LDV (IgG2b; anti-LDV titre > 1:10000; Harry & Plagemann, 1988) . At I h following these pretreatments, the mice received vaginal injections with 6-7 h p.i. LDV-infected cell preparations. Data in Table 4 (cell-associated infection experiments 4 and 5) show that neither of the antibody preparations protected against LDV infection. In experiment 4, without pretreatment, the rate of LDV conversion was 24" 7 %, while pretreatment with chronic plasma (PAb) resulted in a rate of 58"3 % and ascites MAb pretreatment resulted in a rate of 29"4 %. Injection with the chronic plasma alone induced a rate of LDV infection of 26"7 %, despite the low virus titre contained in this preparation; combined with the negative chronic plasma data from experiment 5, the rate of infection with this preparation was 22"2 %. Thus, not only did antibodies fail to protect, but apparently the virus-immune complexes contained in the chronic plasma (Cafruny & Plagemann, 1982a) were themselves infectious, perhaps due to immune enhancement of infection at this body site. These results were confirmed when the 12 h p.i. macrophages were studied in experiment 5. In the absence of pretreatment, the rate of LDV conversion was 63"2 % after vaginal injection of infected macrophages, with the higher rate of infection correlating with later stages of the virus cycle. In this experiment, although chronic plasma alone failed to infect the mice, pretreatment with chronic plasma also failed to suppress infection, since 100% (3/3) of mice became infected. fetuses were examined for both DiI-labelled and LDV-infected cells at 6--16 h post-injection. Fig. 1 illustrates representative data, demonstrating the coincident detection of placental cells which were both DiI-positive (red fluorescence) and LDV antigen-positive by IFA (green fluorescence). The detection of these double-labelled cells at 6 h post-injection shows that exogenously LDV-infected macrophages lodged in the placenta within this time period. Detection of double-labelled cells at 16 h post-injection is most likely due to in vivo acquisition of LDV infection by injected DiI-labelled macrophages, during or after transport to the placenta. Therefore, these results confirm the potential of the LDV-infected macrophage to serve as a vehicle for placental infection, as well as the infectibility of DiI-labelled macrophages.
Placental tracking of Dil-labelled/LDV-infected macrophages
Discussion
These results demonstrate the rapid and widespread tissue distribution of exogenous macrophages following i.v. injection into mice. The tissue distribution of i.p.-injected macrophages was similarly widespread but quantitatively reduced. Combined with the short half-life of labelled macrophages in the blood and the lack of a significant effect of perfusion on tissue distribution, these data suggest that the majority of injected macrophages became adherent to or penetrated vascular endothelia. These results also show that in an allogeneic system, the macrophages were not acutely destroyed, and some labelled cells remained detectable for up to 1 week post-injection. These observations are in accord with ;01(
iii Yii ii i iiiiiiiiiiiiiiiiiiiiii the lack of toxicity of Dil for cultured macrophages as well as the failure of DiI to transfer from cell to cell in viva (Rosen & Gordon, 1990) . Thus, our data confirm and extend previous observations on the survival of DiI-labelled macrophages in viva (Rosen & Gordon, 1990) , Screening of fetuses from pregnant mice injected i.v. with DiI-labelled cells failed to yield any positive cells. However, placentas did become infiltrated with DiI-labelled macrophages. Thus, our data demonstrate a good macrophage barrier between the placenta and fetus. In pregnant mice receiving DiI-labelled allogeneic macrophages by vaginal injection, no systemic distribution of the macrophages was observed, since they failed to appear in the blood or spleen. However, the vaginally injected macrophages did gain access to some placentas and their appearance at this site was anatomically restricted to placentas proximal to the cervix. These results indicate that the macrophages had passed through the cervical canal, entered the uterus and penetrated nearby placental tissues, since they were not simply attached to the placenta surface but rather were present internally in sectioned tissue. This concept is reinforced by the lack of systemic distribution in the pregnant mother as well as the failure to detect DiI-labelled cells in placentas proximal to the uterine horns. The different anatomical location between i.v. and vaginally injected macrophages also suggests different routes of penetration. Fetuses were protected from macrophage penetration, most likely due to their protective membranes (Rugh, 1969) . A barrier to fetal entry is also consistent with immunological protection of fetuses observed when the mother is both LDV-infected and immune (Broen et al., 1992; Haven et al., 1996) . Such protection would not be expected if LDV-infected macrophages were able to enter the fetus.
Our studies directly addressed the question of whether vaginally delivered, LDV-infected macrophages could mediate virus infection. The approach was facilitated by utilizing infected cell populations which were either in early or late phases of virus infection and for which virus supernatant titres were below the threshold dose for free virus infection. The results of these studies yielded significant infection rates for mice receiving early-phase LDV-infected cells intravaginalty, while the infecting cell supernatants injected vaginally by the same technique failed to induce infection. Experiments with LDV-infected cells at later stages of virus replication confirmed these data and yielded higher rates of infection. Whether the increased rates of infection were due to the later stage of infection in the macrophages or to their interaction with higher free virus levels is not clear from our results. We conclude from these experiments that LDV-infected macrophages are capable of transmitting infection when vaginally injected. Further studies will be necessary to clarify the mechanism of infection delivery by virus-infected macrophages. Since an LDV-infected macrophage may produce up to 104 IDa0 (Stueckemann et al., 1982) , one explanation could be the cytocidal release of large numbers of virions in viva, and this could account for the higher rates of infection observed with 12-16 h p.i. macrophages. Furthermore, there appears to be a dynamic interaction between LDV-infected macrophages and vaginal tissues, as suggested by the appearance in some experiments of DiIlabelled macrophages in vaginal tissue as well as in placenta after vaginal administration. The finding of placental macrophages expressing virus antigens and labelled with DiI provides direct evidence that infected macrophages can interact with and penetrate into tissues. Thus, several mechanisms may contribute to the ability of the infected macrophage to serve as a vehicle for infection. The experimental variations we observed in placental macrophage quantification and immune complex-induced infection rates, as well as the variation in free virus threshold, ranging between 105a-106a IDs0, make it likely that regulation of macrophage and virus behaviour after vaginal delivery is complex and depends on other unknown variables. Further studies will be necessary to define these factors.
Neither monoclonal nor polyclonal IgG anti-LDV antibodies injected intravaginally protected mice from cellassociated LDV infection upon subsequent vaginal injection of LDV-infected macrophages. Furthermore, mice receiving polyclonal IgG anti-LDV antibodies alone intravaginally, which contained virus-antibody complexes (Cafruny & Plagemann, 1982a) , displayed significant infection rates, even though the flee virus dose was below the MID, suggesting the possibility of immune enhancement (Cafruny & Plagemann, 1982a) of vaginal LDV infection. These results are consistent with the general failure of either vaccines or infection-induced immunity to control systemic LDV infection (Plagemann & Moennig, 1992; Plagemann et al., 1995; Cafruny et al., 1986) , as well as the potential for infected macrophages to subvert immune defences.
In summary, these results describe the widespread penetration of exogenous macrophages into tissues of mice after i.v. or i.p. injection, and demonstrate local penetration of macrophages from the vagina into placentas proximal to the cervix. Thus, internal spread of virus-infected macrophages would be expected to be highly efficient, in agreement with previous suggestions of 'Trojan Horse' virus-infected monocytes (Levy, 1988; Peluso et al., 1985; Ham et al., 1989; Williams & Blakemore, 1990) . LDV-infected macrophages were also shown to function as infection delivery vehicles when injected into the vaginas of uninfected mice, and were capable of penetrating intact into the placenta, extending the Trojan Horse concept. Although the presence of LDV in semen has not been directly demonstrated due to technical difficulties in obtaining semen from mice (Anderson el al., 1995; King et al., 1994) , other viruses of the arterivirus group (equine arteritis virus and porcine reproductive and respiratory syndrome virus) appear in semen and are sexually transmitted (Meredith, 1993; Timoney & McCollum, I993) . Thus, our data provide a potential mechanism for sexual LDV transmission (Anderson et al., 1995) . The demonstration of experimental cell-associated
